The first noncoordinated phosphonium diylide, [Me2P(C13H8)2]-, and its ylidic and cationic counterparts: synthesis, structural characterization, and interaction with the heavy group 2 metals.

Treatment of potassium or lithium fluorenide with MePCl2 generates the organophosphine MeP(C13H9)2, which on reaction with methyl iodide produces the phosphonium species [Me2P(C13H9)2]I in 74% yield. In the solid state, H...I contacts of < 3.3 A help generate a layered structure in which the fluorenyl rings are nearly parallel. On subsequent reaction of [Me2P(C13H9)2]I with either KH or K[N(SiMe3)2], the corresponding neutral phosphoylide, Me2P(C13H9)(C13H8), forms in 67% yield and was structurally characterized. The phosphonium iodide [Me2P(C13H9)2]I was allowed to react with Ae[N(SiMe3)2]2 (Ae = Ca, Ba), and the product from the reaction with the calcium complex was structurally identified as the salt [CaI(thf)5][Me2P(C13H8)2]. The anion, which is outside the coordination sphere of the calcium, represents the first structurally authenticated example of a free phosphonium diylide. The P-C(ylidic) bond length of 1.748(4) A reflects some partial multiple bond character. 1H and 31P NMR spectra suggest that the barium analogue is similar. Density functional theory calculations were performed on representative phosphonium diylides as an aid to interpreting the bonding in this class of compounds. Despite the strong electrostatic attraction that usually drives metal-ligand binding in highly ionic systems, calcium and barium prefer to coordinate to a single iodide ion and several neutral oxygen donors rather than to the charged diylide.

Structure of 5-hydroxy-2-hydroxymethyl-1-methylpyrid-4-one and 13C NMR relaxation studies of its gadolinium(III) complex.

In order to further elucidate the properties and biological behavior of 5-hydroxy-2-hydroxymethyl-1-methylpyrid-4-one (M1), its X-ray structure has been determined, and the ability of its gadolinium complex to enhance the relaxation of 13C nuclei has been examined. X-ray analysis using Mo K alpha radiation shows that M1 crystallizes in the monoclinic space group C2/c with a complex intermolecular array of hydrogen bonding. No water molecules were present within the unit cell. Gd(M1)2NO3 x 3H2O has been prepared and found to be very soluble in water. The effect of low concentrations of Gd(III) on enhancing the 13C relaxation times of M1 was examined. Trace amounts of Gd(NO3)3 x 6H2O resulted in significant decreases in the relaxation time of certain carbon atoms relative to the control measurements, and these data indicate that carbon atoms which bear donor atoms for Gd(III) undergo a significantly greater relaxation than the other carbons. The water solubility and hydrophilic character of this complex suggest that it may prove useful for the determination of metal binding sites on peptides and oligonucleotides.

Synthesis and iron(III) binding properties of 3-hydroxypyrid-4-ones derived from kojic acid.

In an attempt to reduce the toxicity of the 3-hydroxypyrid-4-ones, the more hydrophilic derivatives of kojic acid were explored and compared to the standard, 1,2-dimethyl-3-hydroxypyrid-4-one, L1. The synthesis and iron(III) binding properties of these chelators are described. Neither these compounds nor the clinically effective 1,2-dimethyl-3-hydroxypyrid-4 one is able to completely remove all of the iron(III) from the Fe(III)EDTA complex in sodium acetate buffered solutions, when the 3-hydroxypyrid-4-one: Fe(III) ratio is 6:1. The ability of these compounds to enhance the urinary excretion of iron in rats indicates that the behavior of the 3-hydroxypyrid-4-ones derived from kojic acid is comparable to the analogous derivatives of maltol and ethyl maltol. The structure of the iron(III) complex of 3-hydroxy-6-hydroxymethyl-1-methylpyrid-4-one was determined by x-ray diffraction and found to be similar to the previously reported structure of the iron(III) complex of L1.